FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000936213> ?p ?o ?g. }

• W2000936213 endingPage "2312" @default.
• W2000936213 startingPage "2305" @default.
• W2000936213 abstract "To review the literature addressing the economic outcomes of nonadherence in the treatment of schizophrenia, and to utilize the review results to provide an update on the economic impact of hospitalizations among schizophrenia patients related to antipsychotic nonadherence.A structured search of EMBASE, Ovid MEDLINE, PubMed and PsycINFO for years 1995-2007 was conducted to identify published English-language articles addressing the economic impact of antipsychotic nonadherence in schizophrenia. The following key words were used in the search: compliance, noncompliance, adherence, nonadherence, relapse, economic, cost, and schizophrenia. A bibliographic search of retrieved articles was performed to identify additional studies. For a study to be included, the date of publication had to be from 1/1/1995 to 6/1/2007, and the impact of nonadherence had to be measured in terms of direct healthcare costs or inpatient days. Subsequently, an estimate of incremental hospitalization costs related to antipsychotic non adherence was extrapolated at the US national level based on the reviewed studies (nonadherence rate and hospitalization rate) and the National Inpatient Sample of Healthcare Cost and Utilization Project (average daily hospitalization costs).Seven studies were identified and reviewed based on the study design, measurement of medication nonadherence, study setting, and cost outcome results. Despite the varied adherence measures across studies, all articles reviewed showed that antipsychotic nonadherence was related to an increase in hospitalization rate, hospital days or hospital costs. We also estimated that the national rehospitalization costs related to antipsychotic nonadherence was $1479 million, ranging from $1392 million to $1826 million in the US in 2005.The estimate of rehospitalization costs was restricted to schizophrenia patients from the Medicaid program. Additionally, the studies we reviewed did not capture the newer antipsychotic drugs (ziprasidone, aripiprazole and paliperidone). Thus, the nonadherence rates or rehospitalization rates might have changed after these new drugs came to the market, which could limit our cost estimation.Poor adherence to antipsychotic medications was consistently associated with higher risk of relapse and rehospitalization and higher hospitalization costs. To reduce the cost of hospitalizations among schizophrenia patients, it seems clear that efforts to increase medication adherence should be undertaken." @default.
• W2000936213 created "2016-06-24" @default.
• W2000936213 creator A5020991724 @default.
• W2000936213 creator A5054437743 @default.
• W2000936213 creator A5074307362 @default.
• W2000936213 creator A5075257656 @default.
• W2000936213 date "2007-08-13" @default.
• W2000936213 modified "2023-09-25" @default.
• W2000936213 title "Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States" @default.
• W2000936213 cites W1519933764 @default.
• W2000936213 cites W193513270 @default.
• W2000936213 cites W1982792695 @default.
• W2000936213 cites W1983341781 @default.
• W2000936213 cites W2022496892 @default.
• W2000936213 cites W2028636935 @default.
• W2000936213 cites W2034342082 @default.
• W2000936213 cites W2052760263 @default.
• W2000936213 cites W2069024810 @default.
• W2000936213 cites W2080716508 @default.
• W2000936213 cites W2099123602 @default.
• W2000936213 cites W2109070861 @default.
• W2000936213 cites W2116225616 @default.
• W2000936213 cites W2137665561 @default.
• W2000936213 cites W2138418531 @default.
• W2000936213 cites W2142091547 @default.
• W2000936213 cites W2142137592 @default.
• W2000936213 cites W2144234230 @default.
• W2000936213 cites W2159155203 @default.
• W2000936213 cites W2162391751 @default.
• W2000936213 cites W2169942008 @default.
• W2000936213 cites W2310399942 @default.
• W2000936213 cites W2916950229 @default.
• W2000936213 cites W51592897 @default.
• W2000936213 doi "https://doi.org/10.1185/030079907x226050" @default.
• W2000936213 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17697454" @default.
• W2000936213 hasPublicationYear "2007" @default.
• W2000936213 type Work @default.
• W2000936213 sameAs 2000936213 @default.
• W2000936213 citedByCount "172" @default.
• W2000936213 countsByYear W20009362132012 @default.
• W2000936213 countsByYear W20009362132013 @default.
• W2000936213 countsByYear W20009362132014 @default.
• W2000936213 countsByYear W20009362132015 @default.
• W2000936213 countsByYear W20009362132016 @default.
• W2000936213 countsByYear W20009362132017 @default.
• W2000936213 countsByYear W20009362132018 @default.
• W2000936213 countsByYear W20009362132019 @default.
• W2000936213 countsByYear W20009362132020 @default.
• W2000936213 countsByYear W20009362132021 @default.
• W2000936213 countsByYear W20009362132022 @default.
• W2000936213 countsByYear W20009362132023 @default.
• W2000936213 crossrefType "journal-article" @default.
• W2000936213 hasAuthorship W2000936213A5020991724 @default.
• W2000936213 hasAuthorship W2000936213A5054437743 @default.
• W2000936213 hasAuthorship W2000936213A5074307362 @default.
• W2000936213 hasAuthorship W2000936213A5075257656 @default.
• W2000936213 hasConcept C118552586 @default.
• W2000936213 hasConcept C121955636 @default.
• W2000936213 hasConcept C142724271 @default.
• W2000936213 hasConcept C144133560 @default.
• W2000936213 hasConcept C17744445 @default.
• W2000936213 hasConcept C194828623 @default.
• W2000936213 hasConcept C199539241 @default.
• W2000936213 hasConcept C204787440 @default.
• W2000936213 hasConcept C2776412080 @default.
• W2000936213 hasConcept C2779473830 @default.
• W2000936213 hasConcept C2779549880 @default.
• W2000936213 hasConcept C2780454255 @default.
• W2000936213 hasConcept C2780494398 @default.
• W2000936213 hasConcept C6964187 @default.
• W2000936213 hasConcept C71924100 @default.
• W2000936213 hasConceptScore W2000936213C118552586 @default.
• W2000936213 hasConceptScore W2000936213C121955636 @default.
• W2000936213 hasConceptScore W2000936213C142724271 @default.
• W2000936213 hasConceptScore W2000936213C144133560 @default.
• W2000936213 hasConceptScore W2000936213C17744445 @default.
• W2000936213 hasConceptScore W2000936213C194828623 @default.
• W2000936213 hasConceptScore W2000936213C199539241 @default.
• W2000936213 hasConceptScore W2000936213C204787440 @default.
• W2000936213 hasConceptScore W2000936213C2776412080 @default.
• W2000936213 hasConceptScore W2000936213C2779473830 @default.
• W2000936213 hasConceptScore W2000936213C2779549880 @default.
• W2000936213 hasConceptScore W2000936213C2780454255 @default.
• W2000936213 hasConceptScore W2000936213C2780494398 @default.
• W2000936213 hasConceptScore W2000936213C6964187 @default.
• W2000936213 hasConceptScore W2000936213C71924100 @default.
• W2000936213 hasIssue "10" @default.
• W2000936213 hasLocation W20009362131 @default.
• W2000936213 hasLocation W20009362132 @default.
• W2000936213 hasOpenAccess W2000936213 @default.
• W2000936213 hasPrimaryLocation W20009362131 @default.
• W2000936213 hasRelatedWork W2044398915 @default.
• W2000936213 hasRelatedWork W2109454496 @default.
• W2000936213 hasRelatedWork W2110640372 @default.
• W2000936213 hasRelatedWork W2292275194 @default.
• W2000936213 hasRelatedWork W2474679401 @default.
• W2000936213 hasRelatedWork W2903287184 @default.
• W2000936213 hasRelatedWork W2905550036 @default.

• next